AI Assistant
Blog
Pricing
Log In
Sign Up
Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.